Hellstrom KE - Search Results

1

Mesothelin-family proteins and diagnosis of mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Robinson BW, et al. Among authors: hellstrom i, hellstrom ke. Lancet. 2003 Nov 15;362(9396):1612-6. doi: 10.1016/S0140-6736(03)14794-0. Lancet. 2003. PMID: 14630441

2

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.

Schummer M, Drescher C, Forrest R, Gough S, Thorpe J, Hellström I, Hellström KE, Urban N. Schummer M, et al. Among authors: hellstrom i, hellstrom ke. Gynecol Oncol. 2012 Apr;125(1):65-9. doi: 10.1016/j.ygyno.2011.11.050. Epub 2011 Dec 7. Gynecol Oncol. 2012. PMID: 22155417 Free PMC article. Clinical Trial.

3

Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.

Johnston FM, Tan MC, Tan BR Jr, Porembka MR, Brunt EM, Linehan DC, Simon PO Jr, Plambeck-Suess S, Eberlein TJ, Hellstrom KE, Hellstrom I, Hawkins WG, Goedegebuure P. Johnston FM, et al. Among authors: hellstrom i, hellstrom ke. Clin Cancer Res. 2009 Nov 1;15(21):6511-8. doi: 10.1158/1078-0432.CCR-09-0565. Epub 2009 Oct 20. Clin Cancer Res. 2009. PMID: 19843662 Free PMC article.

4

Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients.

Hellstrom I, Friedman E, Verch T, Yang Y, Korach J, Jaffar J, Swisher E, Zhang B, Ben-Baruch G, Tan MC, Goedegebuure P, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1520-6. doi: 10.1158/1055-9965.EPI-08-0039. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559570

5

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other.

Hellstrom I, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Adv Exp Med Biol. 2008;622:15-21. doi: 10.1007/978-0-387-68969-2_2. Adv Exp Med Biol. 2008. PMID: 18546615 Review.

6

Soluble mesothelin-related protein--a blood test for mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Robinson BW, et al. Among authors: hellstrom i, hellstrom ke. Lung Cancer. 2005 Jul;49 Suppl 1:S109-11. doi: 10.1016/j.lungcan.2005.03.020. Lung Cancer. 2005. PMID: 15950789

7

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

Hellstrom I, Raycraft J, Kanan S, Sardesai NY, Verch T, Yang Y, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1014-20. doi: 10.1158/1055-9965.EPI-05-0334. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702385

8

MESOMARK: a potential test for malignant pleural mesothelioma.

Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, Miller MC, Verch T, Allard WJ, Pass HI, Sardesai NY. Beyer HL, et al. Among authors: hellstrom i, hellstrom ke. Clin Chem. 2007 Apr;53(4):666-72. doi: 10.1373/clinchem.2006.079327. Epub 2007 Feb 8. Clin Chem. 2007. PMID: 17289801 Clinical Trial.

9

Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.

Yu-Rice Y, Edassery SL, Urban N, Hellstrom I, Hellstrom KE, Deng Y, Li Y, Luborsky JL. Yu-Rice Y, et al. Among authors: hellstrom ke. Reproduction. 2017 Mar;153(3):277-284. doi: 10.1530/REP-16-0265. Epub 2016 Dec 13. Reproduction. 2017. PMID: 27965399 Free PMC article.

10

Clinical evaluation of BR96 sFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinoma.

Henry CJ, Buss MS, Hellström I, Hellström KE, Brewer WG, Bryan JN, Siegall CB. Henry CJ, et al. Among authors: hellstrom i, hellstrom ke. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):751-5. Clin Cancer Res. 2005. PMID: 15701865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results